LOADING
Comparing Visa Inc (V) and Johnson & Johnson (JNJ) across the Financials and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | V | JNJ |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $675.6B | $623.3B |
| P/E Ratio | 30.7 | 30.7 |
| Forward P/E | 24.0 | 21.0 |
| PEG Ratio | 1.64 | 2.82 |
| EPS | $11.71 | $8.43 |
| Revenue Growth (YoY) | 14.4% | 6.6% |
| Profit Margin | 50.8% | 21.5% |
| Return on Equity | 61.2% | 25.7% |
| Dividend Yield | 0.75% | 1.98% |
| Beta | 0.76 | 0.23 |
| 52-Week High | $385.57 | $281.07 |
| 52-Week Low | $292.74 | $178.89 |
| Volume | -- | -- |
Visa Inc is the larger company by market capitalization. Johnson & Johnson trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Johnson & Johnson offers a higher dividend yield for income investors. Visa Inc has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.